With patients at the forefront of everything we do, subrosa Health & Capital, a global consulting and execution services group, enables Rare Disease and Biotech originators to achieve accelerated access to any commercialization pathway, any market, to patients, to elite talent and to capital – from early drug development to launch by a worldwide connected, intelligent, and trusted ecosystem.
subrosa combines strategic market access decision optimization, end-to-end medical, commercial & regulatory launch services, executive search, our proprietary global patient database, unique clinical programs for early patient identification, holistic patient solutions and commercial partnering under one roof to reduce complexity, shorten timelines, achieve your commercial goals faster and leave no patient behind.